Is Apnimed, Inc. (APMD) a Buy, Sell, or Hold?
NASDAQ : APMD
Apnimed, Inc.
$27 USD
-$0.88 (-3.16%)
- Volume
- 160.89K
- Average Volume
- 898.33K
- Market Capitalization
- $1.08B
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $29.15
- Year Low
- $16.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
Company Overview
NASDAQ
Kevin R. Lind
Biotechnology
Healthcare
APMD
65
US
USD
Liquidity Metrics
Sales & Valuation
-$
Profitability
-$
%
%
%
%
P/E Metrics
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| John W. Cronin | Chief Medical Officer |
| Lawrence G. Miller | Founder & Vice Chair of the Board |
| Luigi Taranto Montemurro | Co-Founder & Chief Scientific Officer |
| Sean Johnston | Consulting Head of CMC |
| Dennis Molnar | President & COO |
| Kevin Robert Lind | CEO & Director |
| Michael Kelly | Chief Financial Officer |
| Steven W. Spector | Chief Legal Officer & Head of Corporate Affairs |
| Jennifer Patterson | Senior Vice President of Human Resources |
| Leila Sylvain | Senior Manager of Administration |
Poll Results
No votes yet today — be the first to share your view!
About Apnimed, Inc. (NASDAQ:APMD) Stock
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. ...
2026-08-03 16:35:00
CAMBRIDGE, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed”), a late stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced the closing of its upsized initial public offering of an aggregate of 13,800,000 shares of its common stock, including the full exercise by the underwriters of their overallotment option to purchase 1,800,000 additional shares, at an initial public offering price of $16.00 per share.
Sleep apnea pill developer Apnimed targets $608 million valuation in US IPO
2026-07-27 08:16:43
Late-stage drug developer Apnimed is targeting a valuation of up to $608 million in its initial public offering in the United States.
Apnimed Seeks IPO For OSA Treatment Commercialization
2026-07-23 10:38:59
Apnimed, Inc. is pursuing an IPO to fund regulatory approval and initial commercialization of its lead OSA drug, Oxnimbi (AD109). AD109 has shown strong efficacy in Phase 3 trials and an FDA decision is expected within a year, assuming no delays. APMD recently monetized its Shionogi JV interest, sharpening focus on regulatory and commercial execution for its sole product.
Frequently Asked Questions
-
What is the current Apnimed, Inc. (APMD) stock price?
-
Apnimed, Inc.(NASDAQ:APMD) stock price is $27 in the last trading session. During the trading session, APMD stock reached the peak price of $29.15 while $16.12 was the lowest point it dropped to. The percentage change in APMD stock occurred in the recent session was --3.16% while the dollar amount for the price change in APMD stock was -$0.88.
-
APMD's industry and sector of operation?
-
The NASDAQ listed APMD is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of APMD?
-
John W. Cronin | Chief Medical Officer
Lawrence G. Miller | Founder & Vice Chair of the Board
Luigi Taranto Montemurro | Co-Founder & Chief Scientific Officer
Sean Johnston | Consulting Head of CMC
Dennis Molnar | President & COO -
How many employees does APMD have?
-
Number of APMD employees currently stands at 65. APMD operates from 39 John F. Kennedy Street, Cambridge, MA 02138, US.
-
Link for APMD official website?
-
Official Website of APMD is: https://apnimed.com
-
How do I contact APMD?
-
APMD could be contacted at phone #None and can also be accessed through its website. APMD operates from 39 John F. Kennedy Street, Cambridge, MA 02138, US.
-
How many shares of APMD are traded daily?
-
The average number of APMD shares traded daily for last 3 months was 898.33K.
-
What is the market cap of APMD currently?
-
The market value of APMD currently stands at $1.08B with its latest stock price at $27